Royalty Pharma plc (NASDAQ:RPRX) Q3 2024 Earnings Call Transcript November 6, 2024 Royalty Pharma plc misses on earnings expectations. Reported EPS is $0.918 EPS, expectations were $0.93. Operator: ...
Royalty Pharma (RPRX) delivered a robust performance in Q4 2025, surpassing analyst expectations with an earnings per share (EPS) of $1.47 compared to the forecasted $1.25, marking a 17.6% positive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results